Advanced Flower Capital Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
24.9%projected annual EPS growth
Analyst Coverage
1analyst covering
FY Revenue (est.)
$32.8Mnext fiscal year
FY EPS (est.)
$1.14next fiscal year
Monitoring Framework
Key Performance Indicators
Net Asset Value (NAV) per Share Quarterly7.9Target: Maintain or grow above $7.90
Net Investment Income (NII) per Share Quarterly0.2Target: Cover or exceed the quarterly dividend of $0.05
Net Debt-to-Equity Ratio Quarterly48.0%Target: Below the regulatory BDC limit of 2.0x (or 1.5x asset coverage)
Total Investment Portfolio at Fair Value Quarterly279.2MTarget: Expand through lower middle-market originations
Watch Items
- Deteriorating credit quality and non-accrual status of legacy cannabis loansTrigger: Non-accrual loans exceeding 15% of total portfolio carrying valueAction: Increase CECL reserves, initiate restructuring or forbearance agreements, and accelerate capital recovery efforts.
- Execution of the $5.0 million share repurchase programTrigger: Share price trading significantly below NAV per share ($7.90) and at or below the $3.50 buyback capAction: Execute open-market repurchases under Rule 10b-18 to enhance shareholder value and support the stock price.
- Federal cannabis policy delays (e.g., SAFER Banking Act or DEA rescheduling)Trigger: Official regulatory delays or negative legislative updates regarding Schedule III reschedulingAction: Re-evaluate borrower cash flow projections, adjust risk premiums on cannabis-related debt, and pivot originations toward non-cannabis lower middle-market sectors.
Research as of 19 Jun 2026